TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease

被引：80
|
作者：
Luo, Fei [1 ,2 ]
Oldoni, Federico [2 ]
Das, Avash [2 ]
机构：
[1] Cent South Univ, Xiangya Hosp 2, Dept Cardiovasc Med, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX USA
来源：
HEPATOLOGY COMMUNICATIONS | 2022年 / 6卷 / 03期
基金：
中国国家自然科学基金;
关键词：
SUPERFAMILY MEMBER 2; GENOME-WIDE ASSOCIATION; HEPATIC STEATOSIS; E167K VARIANT; MENDELIAN RANDOMIZATION; CONFERS SUSCEPTIBILITY; PNPLA3; RS738409; COMMON VARIANTS; LIPID-LEVELS; RISK;
D O I：
10.1002/hep4.1822
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Transmembrane 6 superfamily member 2 (TM6SF2) is located on chromosome 19 (19p12) and encodes for a protein of undetermined function. Genetic studies have reported the association between a nonsynonymous variant in TM6SF2 (E167K, rs58542926) with hepatic triglyceride content and its impact on the cardiovascular system. Clinical and epidemiological studies have confirmed the role of TM6SF2 in the development of nonalcoholic fatty liver disease (NAFLD). Recently, TM6SF2 was also shown to play an important role in promoting hepatic fibrosis and hepatocellular cancer in mouse models. This review aims to capture the physiological role of TM6SF2 in the regulation of lipid metabolism and its involvement in cardiometabolic diseases.
引用
收藏
页码：448 / 460
页数：13
相关论文
共 50 条
  • [21] Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
    Hamaguchi, Masahide
    Kojima, Takao
    Takeda, Noriyuki
    Nagata, Chisato
    Takeda, Jun
    Sarui, Hiroshi
    Kawahito, Yutaka
    Yoshida, Naohisa
    Suetsugu, Atsushi
    Kato, Takahiro
    Okuda, Junichi
    Ida, Kazunori
    Yoshikawa, Toshikazu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (10) : 1579 - 1584
  • [22] Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
    Masahide Hamaguchi
    Takao Kojima
    Noriyuki Takeda
    Chisato Nagata
    Jun Takeda
    Hiroshi Sarui
    Yutaka Kawahito
    Naohisa Yoshida
    Atsushi Suetsugu
    Takahiro Kato
    Junichi Okuda
    Kazunori Ida
    Toshikazu Yoshikawa
    World Journal of Gastroenterology, 2007, (10) : 1579 - 1584
  • [23] Research progress on the relationship between TM6SF2 rs58542926 polymorphism and non-alcoholic fatty liver disease
    Xue, Wan-Ying
    Zhang, Li
    Liu, Chuan-Miao
    Gao, Yu
    Li, Shu-Jing
    Huai, Zi-You
    Dai, Jing
    Wang, Yuan-Yuan
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (02) : 97 - 107
  • [24] The TM6SF2 rs58542926 T allele is significantly associated with non-alcoholic fatty liver disease in Chinese
    Wang, Xiaoliang
    Liu, Zhipeng
    Peng, Zhihai
    Liu, Wanqing
    JOURNAL OF HEPATOLOGY, 2015, 62 (06) : 1438 - 1439
  • [25] TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
    Liu, Yang-Lin
    Reeves, Helen L.
    Burt, Alastair D.
    Tiniakos, Dina
    McPherson, Stuart
    Leathart, Julian B. S.
    Allison, Michael E. D.
    Alexander, Graeme J.
    Piguet, Anne-Christine
    Anty, Rodolphe
    Donaldson, Peter
    Aithal, Guruprasad P.
    Francque, Sven
    Van Gaal, Luc
    Clement, Karine
    Ratziu, Vlad
    Dufour, Jean-Francois
    Day, Christopher P.
    Daly, Ann K.
    Anstee, Quentin M.
    NATURE COMMUNICATIONS, 2014, 5
  • [26] TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
    Yang-Lin Liu
    Helen L. Reeves
    Alastair D. Burt
    Dina Tiniakos
    Stuart McPherson
    Julian B. S. Leathart
    Michael E. D. Allison
    Graeme J. Alexander
    Anne-Christine Piguet
    Rodolphe Anty
    Peter Donaldson
    Guruprasad P. Aithal
    Sven Francque
    Luc Van Gaal
    Karine Clement
    Vlad Ratziu
    Jean-Francois Dufour
    Christopher P. Day
    Ann K. Daly
    Quentin M. Anstee
    Nature Communications, 5
  • [27] New Glance at the Role of TM6SF2 in Lipid Metabolism and Liver Cancer
    Jiang, Xiaoxiao
    Qian, Hui
    Ding, Wen-Xing
    HEPATOLOGY, 2021, 74 (03) : 1141 - 1144
  • [28] The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients
    Raia, Gamal Y. S.
    Abdelsameea, Eman
    Taie, Dalia Hamdy Twfic
    Elshaarawy, Omar
    Bayomy, Noha Rabie
    Mostafa, Rasha G.
    Alsharnoby, Aml Abd Alhamid
    Diab, Karema Abdelhady
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 8 (03) : 211 - 218
  • [29] Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis
    Zhu, Wenzhen
    Liang, Wenying
    Lu, Haocheng
    Chang, Lin
    Zhang, Jifeng
    Chen, Y. Eugene
    Guo, Yanhong
    CELLS, 2022, 11 (18)
  • [30] ENDOTOXAEMIA IS ASSOCIATED WITH HISTOLOGICAL SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND MAY BE INCREASED IN PATIENTS WITH THE TM6SF2 GENE VARIANTS
    Wong, V. W. -S.
    Wong, G. L. -H.
    Pang, J.
    Chan, A. W. -H.
    Chan, H. -Y.
    Tse, C. -H.
    Shu, S. S. -T.
    Chan, H. L. -Y.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S190 - S190
12345